Education company launches innovative virtual platform at Houston school

back to school

Kïdo Home, a virtual education platform, has launched out of a Houston-area school. Photo via Getty Images

The coronavirus pandemic has spawned an array of digital innovations in education, and one of those innovations has been hatched right here in Houston.

Kïdo, an international network of preschools, recently introduced its first-ever virtual learning platform, with Kïdo's school in Rice Village serving as the U.S. launchpad. The new platform, called Kïdo Home, is offering free trials for parents in the Houston, Austin, and Dallas-Fort Worth areas. Kïdo Home is in the midst of enrolling students nationwide.

The virtual platform in the U.S. rolled out August 7, with classes starting Sept. 1. The Kïdo Home platform already had been up and running in Dubai, Hong Kong, and London, where Kïdo operates brick-and-mortar schools.

Kïdo Home is made up of small-group classes held online and led by trained instructors. Given the massive interruption of in-person education caused by the pandemic, the platform fills a void for 2- to 6-year-olds.

A study conducted this summer by the National Institute for Early Education Research at Rutgers University's Graduate School of Education found U.S. preschoolers were losing two to four months of critical learning due to pandemic-provoked school closures. According to a nationwide survey of parents, nearly three-fourths of American preschoolers had been affected by pandemic shutdowns that started in March. Many parents reported their distance-learning alternatives were lacking, with less than half receiving support for virtual learning within two months of preschool closures.

"Perhaps 10 percent of preschool children received a robust replacement for in-person preschool attendance," Steve Barnett, senior co-director of the Rutgers institute, says in a release.

Kïdo's Rice Village school serves as the U.S. launchpad for the new platform. Photo via kido.school

Adapted from the Kïdo Early Years Program — which blends the Waldorf Steiner, Reggio Emilia, and Montessori methodologies — Kïdo Home is designed to foster imagination, social well-being, motor skills, and creativity in students through its year-long curriculum.

Kïdo Home's key features include interactive touchscreen literacy and math modules, weekly one-on-one sessions with accredited instructors, and monthly home-activity kits covering art, STEM, literacy, and physical development. Those kits complement the online learning components.

Parents receive weekly updates and monthly assessments regarding their child's progress in the virtual program.

"We saw the need to provide a high-quality, affordable, and engaging virtual learning platform months ago when the pandemic was impacting our preschools in Hong Kong," Houston-based Deepanshu Pandita, U.S. CEO of Kïdo, says in a release. "We've conducted in-depth research that showcases the importance of investing in early childhood education, what the right amount of screen time is, and how to keep children engaged remotely."

Kïdo Home's daily two-hour, real-time video lessons eventually will include second-language immersion, just like Kïdo's brick-and-mortar schools do.

The average class ratio for Kïdo Home is around one instructor for every eight students. Minimal to no parental support is required during these classes. The program costs $350 a month.

Kïdo operates brick-and-mortar locations in Houston, Austin, Hong Kong, Dubai, and London, all of which are open. The Houston school, Kïdo's first in the U.S., debuted in May. The Austin location opened in July. Although a free trial of the virtual platform is available in Dallas-Fort Worth, Kïdo doesn't have a school there.

From Your Site Articles
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

NASA unveils Artemis III astronauts at Johnson Space Center in Houston

To the moon

NASA on Tuesday, June 9, revealed the crew for its Artemis III mission, the next step in the space agency's plan to eventually land astronauts on the moon.

The announcement came two months after Artemis II's record-breaking trip around the moon that surpassed the distance record of Apollo 13.

NASA's Randy Bresnik, Frank Rubio, Andre Douglas and the European Space Agency's Luca Parmitano won't fly to the moon or land on the surface. Instead, they’ll orbit Earth while practicing docking their Orion capsule with two lunar landers.

“To the Artemis III crew, we wish you Godspeed on the journey ahead,” said NASA administrator Jared Isaacman.

Elon Musk’s SpaceX and Jeff Bezos’ Blue Origin are racing to deliver the lunar landers. The two-week demo is targeted for 2027. Blue Origin suffered a recent setback when its massive rocket exploded during an engine-firing test on the launch pad in Florida, shaking nearby homes and illuminating the sky with an orange fireball.

NASA's Jeremy Parsons said the setback is a learning opportunity and that the space agency is confident Blue Origin's rocket will be ready in time.

NASA's Artemis program aims to return astronauts to the moon's surface for the first time since the 1970s. A recent revamp of the program announced by Isaacman aims to fast-track it similarly to the Apollo era, adding the upcoming spaceflight around Earth before eyeing a lunar landing in 2028.

“We are certainly humbled as a crew to be able to be your crew that executes this Artemis III mission in space,” said Bresnik, Artemis III commander.

Added Douglas, mission specialist: “My brain — it is going a mile a minute right now. But my heart, it is so warm. It is so full."

In May, NASA awarded hundreds of millions of dollars in contracts to four companies, including Blue Origin, to build landers, rovers and drones for a future moon base. Isaacman said the goal of the moon base is to lay the foundation for a Mars expedition.

Meta to bring $115 million AI data center training initiative to Houston

ai workforce

Meta and Associated Builders and Contractors have entered into a partnership to invest $115 million in training programs for the construction of AI data centers, with a portion of the project launching in Houston.

The companies announced June 8 that they would open America’s Workforce Academies at ABC chapter training centers in Houston; Indianapolis; Baton Rouge, Louisiana; and Columbus, Ohio.

The academies will offer career readiness and safety training, plus five weeks of hands-on education. Participants who complete the program will be granted a job offer from contractors working on Meta projects.

“The AI revolution is bringing change but also historic opportunities,” Dina Powell McCormick, Meta president and vice-chairman, said in a news release. “Skilled workers electrified rural America one pole at a time. They manned the factories that built the arsenal that won World War II. Now a new generation will pour the foundations and lay the fiber that secures American strength in this new age.”

Overall, the Meta and ABC aim for the academies to build a more sustainable pipeline of skilled construction workers and ensure safety and job readiness for the surging number of data center projects underway.

“This new program is an innovative talent solution that is a critical part of addressing the construction industry’s ongoing workforce shortage and creates an accelerated, new-entrant strategy for job seekers ... The sustained demand for data center construction technicians means the industry needs an all-of-the-above approach to address this shortage and grow the construction talent pool,” Michael Bellaman, ABC president and CEO, added in the release.

In Texas, Meta, the parent company of Facebook and Instagram, has launched or broken ground on data centers in El Paso, Fort Worth and Temple. The company announced in March that it planned to grow its El Paso Data center by 1 gigawatt, representing more than a $10 billion investment.

Apart from Meta, Texas has attracted data center development to power other giants like Google and Amazon in recent years. In turn, Texas has been predicted to become the biggest data center market. Commercial real estate services provider JLL reported this spring that the state could topple Northern Virginia as the world’s largest data-center market by 2030. Similarly, CBRE predicted that Houston's data center capacity could double by 2028. Read more here.

New Houston biotech co. lands $30M for pulmonary fibrosis drug

drug money

Most of us can claim a scar or two on our bodies. But when scarring develops inside the body, it’s known as a fibrotic disorder. A freshly launched Houston company, Oorja Bio Inc., is working on a treatment that can help to repair cells and reduce the damage wrought by the growth of fibrotic tissue in patients.

Late last month, Oorja Bio hit the scene with a pair of big announcements. Not only has the company raised a $30 million Series A thanks to founding investor California-based Westlake BioPartners, but it has also already paved the way for a Phase 2 study to take place this year.

Oorja Bio received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to test its treatment in patients with idiopathic pulmonary fibrosis (IPF), a scarring of the lung tissue. IPF affects more than 150,000 adults in the United States and can result in a range of symptoms from shortness of breath to organ failure and death as it progresses.

Oorja Bio’s lead drug candidate, ORJ-001, was shown in a Phase 1 in-human trial to demonstrate “therapeutically relevant exposure and favorable tolerability” in 64 healthy adult volunteers in whom it was administered daily or weekly, according to a news release. Pre-clinical studies of ORJ-001 showed durable target tissue engagement and biomarker activity in bleomycin-induced lung fibrosis.

Administered subcutaneously, ORJ-001 is intended to improve and even restore function in cells that can reduce the signaling that causes IPF. It stops advancement of IPF and also allows for tissue repair. Currently available treatments for the disease can slow the development of IPF down, but do not address the declining lung function that’s inherent in its progression.

“The clinical and preclinical results from our studies to date give us confidence that ORJ-001 represents a novel treatment approach with the potential to repair and reverse fibrosis and modify disease progression in IPF,” Dr. Janethe Pena, CMO of Oorja Bio, said in the release.

“Our team is energized to deliver on our goal of redefining the future of fibrotic diseases, beginning with ORJ-001,” CEO and founder Sujay Kango added. “As we advance ORJ-001 in the clinic, we are embracing the paradigm shift in our biological understanding of IPF pathology that aligns with the central role of the alveolar epithelium. ORJ-001 was designed with this biology in mind and may provide, for the first time, a therapeutic intervention that repairs and reverses fibrosis and promotes disease modification.”

Most patients live only three to five years following their IPF diagnosis. Soon, ORJ-001 and Oorja Bio could give them a fighting chance.

View All Listings